News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|January 23, 2025

Innovations and Impact: The Future of Patient Support Services in Hematology-Oncology

Panelists discuss how they envision the future of industry-provided and other patient support services in hematology-oncology, highlighting potential improvements and innovations that could be implemented in the near future.

Episodes in this series

EP. 1 Challenges at Diagnosis: Navigating the Emotional and Physical Realities of DLBCL and FL

EP. 1 Challenges at Diagnosis: Navigating the Emotional and Physical Realities of DLBCL and FL

EP. 2 Empowering Patients: Strategies for Emotional Resilience and Support in Lymphoma Care

EP. 2 Empowering Patients: Strategies for Emotional Resilience and Support in Lymphoma Care

EP. 3 Tailored Support: The Role of Industry-Provided Services in Lymphoma Care

EP. 3 Tailored Support: The Role of Industry-Provided Services in Lymphoma Care

EP. 4 Seamless Transitions: Supporting Patients Through Treatment, Monitoring, and Maintenance

EP. 4 Seamless Transitions: Supporting Patients Through Treatment, Monitoring, and Maintenance

EP. 5 Innovations and Impact: The Future of Patient Support Services in Hematology-Oncology

EP. 5 Innovations and Impact: The Future of Patient Support Services in Hematology-Oncology

Video content above is prompted by the following:

What do you think is the future of industry-provided and other patient support services in hematology-oncology, and what improvements or innovations would you like to see implemented in the near future?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Expert featured in this series.

New Registry Data on MAC Pulmonary Disease Outcomes

ByAshley Losier, MD

Published: August 31st 2026 | Updated: August 31st 2026

Expert featured in this series.

Top Unmet Needs in MAC Pulmonary Disease Management

ByAshley Losier, MD

Published: August 31st 2026 | Updated: August 31st 2026

The Cost of Waiting: An Endocrinologist's Economic Case for Earlier Metabolic Disease Intervention

ByJaime Almandoz, MD, MBA

August 28th 2026

SYNCHRONIZE-1 Through an Endocrinologist's Lens: Weight Loss Quality, Visceral Fat, and Liver Fat Reduction

ByJaime Almandoz, MD, MBA

August 28th 2026

Remission vs. Response: Redefining Treatment Goals in Major Depressive Disorder

ByKen Cohen, MD,Samuel Wilkinson, MD,Greg Rhee, PhD, FACE,Michael E. Thase, MD,Nisha Bhide, PharmD

August 27th 2026

Trending on AJMC

Multiagonists Outpace Older GLP-1 Drugs for Weight Loss

DOJ Abandons Olmstead Defense as Texas v Kennedy Advances

Midsized Biotechs Strike MFN Drug Pricing Deals

Myasthenia Gravis Linked to Greater Longevity Than Multiple Sclerosis

FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes